Advertisement

Аксеф 250

Основна информация

  • Търговско наименование:
  • Аксеф 250 (Aksef 250)
  • Предлага се от:
  • Нобел Фарма ООД
  • дозиране:
  • 250 mg x 10; x 20
  • Лекарствена форма:
  • филмирани таблетки
  • Композиция:
  • филмирани таблетки 250 mg x 10; x 20
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици
Advertisement

Документи

Локализация

  • Предлага се в:
  • Аксеф 250 (Aksef 250)
    България
  • Език:
  • български

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Последна актуализация:
  • 09-08-2016

Листовка за пациента


13-1-2017

Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use

Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use

Fuji removing legacy 250/450 duodenoscope models from clinical use, replacing with with the ED-530XT model.

FDA - U.S. Food and Drug Administration

6-12-2017

CEFUROXIME AXETIL Tablet, Film Coated [Wockhardt USA LLC.]

CEFUROXIME AXETIL Tablet, Film Coated [Wockhardt USA LLC.]

Updated Date: Dec 6, 2017 EST

US - DailyMed

16-11-2017

CEFUROXIME AXETIL Tablet [Lake Erie Medical DBA Quality Care Products LLC]

CEFUROXIME AXETIL Tablet [Lake Erie Medical DBA Quality Care Products LLC]

Updated Date: Nov 16, 2017 EST

US - DailyMed

16-11-2017

CEFUROXIME AXETIL Tablet [Aurobindo Pharma Limited]

CEFUROXIME AXETIL Tablet [Aurobindo Pharma Limited]

Updated Date: Nov 16, 2017 EST

US - DailyMed

30-10-2017

CEFUROXIME AXETIL Tablet [A-S Medication Solutions]

CEFUROXIME AXETIL Tablet [A-S Medication Solutions]

Updated Date: Oct 30, 2017 EST

US - DailyMed

21-8-2017

X (Cefuroxime Axetil) Powder [AX Pharmaceutical Corp]

X (Cefuroxime Axetil) Powder [AX Pharmaceutical Corp]

Updated Date: Aug 21, 2017 EST

US - DailyMed

1-8-2017

CEFUROXIME AXETIL Tablet [Golden State Medical Supply, Inc.]

CEFUROXIME AXETIL Tablet [Golden State Medical Supply, Inc.]

Updated Date: Aug 1, 2017 EST

US - DailyMed

18-7-2017

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals,Inc.]

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Jul 18, 2017 EST

US - DailyMed

3-7-2017

CEFUROXIME AXETIL Tablet, Film Coated [Unit Dose Services]

CEFUROXIME AXETIL Tablet, Film Coated [Unit Dose Services]

Updated Date: Jul 3, 2017 EST

US - DailyMed

19-6-2017

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals, Inc.]

Updated Date: Jun 19, 2017 EST

US - DailyMed

22-5-2017

CEFUROXIME AXETIL Tablet, Film Coated [Ascend Laboratories, LLC]

CEFUROXIME AXETIL Tablet, Film Coated [Ascend Laboratories, LLC]

Updated Date: May 22, 2017 EST

US - DailyMed

31-1-2017

CEFUROXIME AXETIL Tablet [NorthStar Rx LLC]

CEFUROXIME AXETIL Tablet [NorthStar Rx LLC]

Updated Date: Jan 31, 2017 EST

US - DailyMed

30-1-2017

CEFUROXIME AXETIL Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Jan 30, 2017 EST

US - DailyMed

16-1-2017

EU/3/16/1814 (TREAT U, S.A.)

EU/3/16/1814 (TREAT U, S.A.)

EU/3/16/1814 (Active substance: Doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31-aminoacid peptide targeting nucleolin) - Orphan designation - Commission Decision (2017)218 of Mon, 16 Jan 2017 European Medicines Agency (EMA) procedure number: EMA/OD/250/16

Europe -DG Health and Food Safety

22-12-2016

Scientific guideline:  Draft Crizotinib hard capsules 200 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft Crizotinib hard capsules 200 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of Crizotinib

Europe - EMA - European Medicines Agency

Advertisement